Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06422455 · ClinicalTrials.gov registry record · NA
Access to Genetic Testing in Underserved Patients With Cancer
A NA study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 2
- Study locations
NCT06422455: Recruiting NA study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by University of Southern California.
NCT06422455 is a NA study of Malignant Solid Neoplasm and Breast Carcinoma that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 800 participants, below the 1,136-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06422455, a NA study of Malignant Solid Neoplasm and Breast Carcinoma, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study compares the experiences of people who receive information about genetic testing from a computer-generated character to patients who receive information from a human genetics healthcare provider. Patients with cancer are increasingly recommended for genetic testing as standard of care. Multiple factors contribute to low usage of genetic testing but for many patients the lack of access to genetic counseling and testing is an important and flexible factor. Lack of access is especially relevant to racial/ethnic minority patients and those living in non-metropolitan rural settings who are frequently cared for at safety-net hospitals with limited genetics services. Alternative delivery models are necessary to improve rates of access to genetic testing in patients with cancer. Health information technology is under used by genetics providers. A patient-facing relational agent (PERLA) will provide pre-test genetics education in both English and Spanish across two clinical settings to facilitate more timely access to genetic testing. Using the PERLA intervention may help researchers learn different ways to provide education about genetic testing to patients with cancer compared to usual care.
Primary Outcome
The proportion of participants who receive genetic testing will be reported.
Conditions Studied
Interventions
- OTHER Best Practice
- OTHER Educational Intervention
- OTHER Electronic Health Record Review
- OTHER Interview
- OTHER Genetic Counseling
Study Locations (2)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2023-10-24 |
| Est. Completion | 2028-10-24 |
| Phase | NA |
What NCT06422455 shows while recruiting
NCT06422455 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,136-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (30% lower).
The record links to 8 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Best Practice is the first listed.
NCT06422455 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT06422455 about?
NCT06422455 is a clinical study titled "Access to Genetic Testing in Underserved Patients With Cancer". This study compares the experiences of people who receive information about genetic testing from a computer-generated character to patients who receive information from a human genetics healthcare provider. Patients with cancer are increasingly recommended for genetic testing as standard of care. Mu...
What is the current status of trial NCT06422455?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2023-10-24. Estimated completion is 2028-10-24.
What conditions does trial NCT06422455 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Breast Carcinoma, Metastatic Prostate Carcinoma, Ovarian Carcinoma, Triple-Negative Breast Carcinoma.
What interventions are being tested in trial NCT06422455?
The interventions under investigation include: Best Practice (OTHER), Educational Intervention (OTHER), Electronic Health Record Review (OTHER), Interview (OTHER), Genetic Counseling (OTHER).
Who is sponsoring clinical trial NCT06422455?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06422455 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06422455's enrollment target sits among peer trials
800 20th of 176 higher than 157 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Community-Based Physical Activity Intervention for Underserved Cancer Survivors
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI